Sürdürülebilir Kalkınma Amaçları

• 2

• MakaleYalnız künye2026Scopus SJRQ2/r/munzur/1058
  The Turkish Version of the Self Evaluation of Breathing Questionnaire: Cross-cultural Adaptation, Validity and Reliability

  Ataş, Kübra; Kızmaz, Erhan; Mutlu, Ebru Kaya

  Investigating the validity and reliability of the Turkish version of the Breathing Self-Assessment Questionnaire (SEBQ), a tool for measuring dysfunctional breathing. Ninety-two healthy adults (mean (range) age 29.4 (19–56) years; 39 males) were analysed. The SEBQ was translated and adapted into Turkish. At baseline, data were collected using the SEBQ, Nijmegen Questionnaire (NQ), breath-holding time, and Short Form 36 (SF-36). The SEBQ was repeated within 7–14 days. SEBQ validity was assessed through content, structural, and convergent/divergent validity analyses, while reliability was evaluated for internal consistency, stability, and reproducibility. One item was removed based on exploratory factor analysis. The SEBQ has a two-factor structure and explains 50.1% of total variance, confirmed by confirmatory factor analysis. It has a positive correlation with the NQ and a negative correlation with SF-36 subscales, but not with breath-holding time and general health. The Cronbach’s alpha coefficient was 0.931, and the intraclass correlation coefficient was 0.814. The Standard Error of Measurement and Smallest Real Difference were 5.06 and 15.03, respectively. The SEBQ is well-structured, valid, internally consistent, stable, and reproducible for assessing subjective unexplained respiratory symptoms in the Turkish population.

  • 
  AtıfScopus1·WoS1·OpenAlex3

  İncele
• MakaleYalnız künye2024Scopus SJRQ1/r/munzur/2032
  Virtual reality for COPD exacerbation: A randomized controlled trial

  Kizmaz, Erhan; Telli Atalay, Orçin; Çetin, Nazlı; Uğurlu, Erhan

  Background: Pulmonary rehabilitation (PR) is an effective treatment method for chronic obstructive pulmonary disease (COPD). However, individuals with chronic diseases that require lifelong treatment and experience exacerbations need motivational methods. Objectives: The aim of this study was to examine the effects of virtual reality on symptoms, daily living activity, functional capacity, anxiety and depression levels in COPD exacerbation. Methods: Fifty patients hospitalized for COPD exacerbation were included in the study. They were randomly assigned to two groups. Twenty-five patients participated in a traditional PR (once-daily until discharge), including pedaling exercises. The second/25 patients followed the same protocol but experienced cycling simulation in the forest via virtual reality (VR + PR). All patients were evaluated using 1-minute/Sit-to-Stand test (STST), modified-Medical Research Council (mMRC) scale, COPD Assessment test (CAT), Hospital Anxiety and Depression Scale (HADS), and London Chest Activities of Daily Living (LCADL) before and after the treatment. Results: The STST showed an increase in both groups post-treatment, notably higher in the VR + PR (p = 0.037). Dyspnea levels and CAT scores decreased in all patients, but the decrease was greater in the PR + VR group for both parameters (p = 0.062, p = 0.003; respectively). Both groups experienced a reduction in the HADS scores compared to the pre-treatment, with a more significant decrease in depression and the total score in the VR + PR (p < 0.05). LCADL's sub-parameters and total score, excluding household, decreased in both groups after treatment (p < 0.05). The improvement was more substantial in the VR + PR. Conclusions: Virtual reality provides benefits in the management of COPD exacerbations and can be used safely. Clinical trial registiration: Registered at clinicaltrials.gov, registration ID: NCT05687396, URL: www.clinicaltrials.gov.

  • 
  AtıfScopus11·WoS11·OpenAlex15

  İncele